Showing results (541-550 of 698) with videos related to
Sort By:
Pageof 70
Trauma Surgery & Acute Care Open|July 22, 2026
Impact of a rib fracture treatment protocol: a propensity score matching analysisThermutis Djanie, Ashley Pfaff, Claire Miller, et al.American Journal of Surgery|February 3, 2019
Perceptions in rib injuries: A multidisciplinary single center survey of clinician differences in risk stratification and management of patients with rib fracturesMatthew C Johnson, Claire P Miller, Allan E Stolarski, et al.Gene|August 20, 2018
DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancerStephen P Sharp, Robert A Malizia, Travis Walrath, et al.Clinical Cardiology|March 1, 1991
Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulationH D Gössinger, W Speiser, P Siostrzonek, et al.Human Pathology|December 31, 1997
Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosisH C Bankl, T Radaszkiewicz, B Pikula, et al.British Journal of Haematology|December 31, 1997
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiencyS Mustafa, I Pabinger, K Vàradi, et al.Leukemia|February 13, 2004
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemiaD Heintel, E Kroemer, D Kienle, et al.Annals of Hematology|August 20, 2002
Massive postoperative intramuscular bleeding in acquired von Willebrand's diseaseM Krebs, B Meyer, P Quehenberger, et al.Thrombosis Research|July 1, 1990
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factorsW Speiser, P Speiser, E Minar, et al.Wiener Klinische Wochenschrift|January 1, 1993
[Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma]L Ohler, C Scholten, E Reiter, et al.Pageof 70